FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q85647635> ?p ?o ?g. }

• Q85647635 description "2013 nî lūn-bûn" @default.
• Q85647635 description "2013 թվականին հրատարակված գիտական հոդված" @default.
• Q85647635 description "2013年の論文" @default.
• Q85647635 description "2013年学术文章" @default.
• Q85647635 description "2013年学术文章" @default.
• Q85647635 description "2013年学术文章" @default.
• Q85647635 description "2013年学术文章" @default.
• Q85647635 description "2013年学术文章" @default.
• Q85647635 description "2013年学术文章" @default.
• Q85647635 description "2013年學術文章" @default.
• Q85647635 description "2013年學術文章" @default.
• Q85647635 description "2013年學術文章" @default.
• Q85647635 description "2013年學術文章" @default.
• Q85647635 description "2013年學術文章" @default.
• Q85647635 description "2013년 논문" @default.
• Q85647635 description "article científic" @default.
• Q85647635 description "article scientific" @default.
• Q85647635 description "article scientifique" @default.
• Q85647635 description "articol științific" @default.
• Q85647635 description "articolo scientifico" @default.
• Q85647635 description "artigo científico" @default.
• Q85647635 description "artigo científico" @default.
• Q85647635 description "artigo científico" @default.
• Q85647635 description "artikel ilmiah" @default.
• Q85647635 description "artikull shkencor" @default.
• Q85647635 description "artikulong pang-agham" @default.
• Q85647635 description "artykuł naukowy" @default.
• Q85647635 description "artículo científico publicado en 2013" @default.
• Q85647635 description "artículu científicu" @default.
• Q85647635 description "bilimsel makale" @default.
• Q85647635 description "bài báo khoa học" @default.
• Q85647635 description "naučni članak" @default.
• Q85647635 description "scienca artikolo" @default.
• Q85647635 description "scientific article published in January 2013" @default.
• Q85647635 description "scientific article published in January 2013" @default.
• Q85647635 description "scientific article published on 01 January 2013" @default.
• Q85647635 description "teaduslik artikkel" @default.
• Q85647635 description "tieteellinen artikkeli" @default.
• Q85647635 description "tudományos cikk" @default.
• Q85647635 description "vedecký článok" @default.
• Q85647635 description "vetenskaplig artikel" @default.
• Q85647635 description "videnskabelig artikel udgivet januar 2013" @default.
• Q85647635 description "vitenskapelig artikkel" @default.
• Q85647635 description "vitskapeleg artikkel" @default.
• Q85647635 description "vědecký článek" @default.
• Q85647635 description "wetenschappelijk artikel" @default.
• Q85647635 description "wissenschaftlicher Artikel" @default.
• Q85647635 description "επιστημονικό άρθρο" @default.
• Q85647635 description "мақолаи илмӣ" @default.
• Q85647635 description "наукова стаття, опублікована в січні 2013" @default.
• Q85647635 description "научна статия" @default.
• Q85647635 description "научная статья" @default.
• Q85647635 description "научни чланак" @default.
• Q85647635 description "научни чланак" @default.
• Q85647635 description "מאמר מדעי" @default.
• Q85647635 description "مقالة علمية نشرت في يناير 2013" @default.
• Q85647635 description "জানুয়ারি ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q85647635 description "บทความทางวิทยาศาสตร์" @default.
• Q85647635 description "სამეცნიერო სტატია" @default.
• Q85647635 name "Denosumab treatment of prostate cancer with bone metastases and increased urine N-telopeptide levels after therapy with intravenous bisphosphonates: results of a randomized phase II trial" @default.
• Q85647635 name "Denosumab treatment of prostate cancer with bone metastases and increased urine N-telopeptide levels after therapy with intravenous bisphosphonates: results of a randomized phase II trial" @default.
• Q85647635 name "Denosumab treatment of prostate cancer with bone metastases and increased urine N-telopeptide levels after therapy with intravenous bisphosphonates: results of a randomized phase II trial" @default.
• Q85647635 type Item @default.
• Q85647635 label "Denosumab treatment of prostate cancer with bone metastases and increased urine N-telopeptide levels after therapy with intravenous bisphosphonates: results of a randomized phase II trial" @default.
• Q85647635 label "Denosumab treatment of prostate cancer with bone metastases and increased urine N-telopeptide levels after therapy with intravenous bisphosphonates: results of a randomized phase II trial" @default.
• Q85647635 label "Denosumab treatment of prostate cancer with bone metastases and increased urine N-telopeptide levels after therapy with intravenous bisphosphonates: results of a randomized phase II trial" @default.
• Q85647635 prefLabel "Denosumab treatment of prostate cancer with bone metastases and increased urine N-telopeptide levels after therapy with intravenous bisphosphonates: results of a randomized phase II trial" @default.
• Q85647635 prefLabel "Denosumab treatment of prostate cancer with bone metastases and increased urine N-telopeptide levels after therapy with intravenous bisphosphonates: results of a randomized phase II trial" @default.
• Q85647635 prefLabel "Denosumab treatment of prostate cancer with bone metastases and increased urine N-telopeptide levels after therapy with intravenous bisphosphonates: results of a randomized phase II trial" @default.
• Q85647635 P1433 Q85647635-AD214D7D-B702-4C5C-9056-0D46C5703C5E @default.
• Q85647635 P1476 Q85647635-1CD71379-CB80-4E00-BD7A-74FDA4DF29EA @default.
• Q85647635 P2093 Q85647635-0F08BDA7-4540-490D-8709-22B08F6D3D07 @default.
• Q85647635 P2093 Q85647635-3C53A8D5-0C00-4F12-8C23-FDB696DC5358 @default.
• Q85647635 P2093 Q85647635-68560180-9208-4E38-86C7-B362D1F93F13 @default.
• Q85647635 P2093 Q85647635-AE46A74D-9FB8-44C6-A852-5BF38E2B300E @default.
• Q85647635 P2093 Q85647635-BC0C9276-8852-4B76-BAD2-CD09B00B7D6B @default.
• Q85647635 P304 Q85647635-DCC809E8-0893-4E4F-B0F2-AFF8394483D0 @default.
• Q85647635 P31 Q85647635-8E1F4D32-8AE1-4876-AE91-340396A55B31 @default.
• Q85647635 P356 Q85647635-CD87765D-812C-4C27-A470-023DE8F26306 @default.
• Q85647635 P433 Q85647635-2D3B068A-6B33-4A90-AB73-91398B95CEF0 @default.
• Q85647635 P478 Q85647635-86722818-6471-4922-BC33-CA18C3867F4A @default.
• Q85647635 P577 Q85647635-A2EC7447-EDD5-4C6C-894B-0FAB46AD4CAF @default.
• Q85647635 P698 Q85647635-18322DED-5C86-4B15-8EC4-89F541A15548 @default.
• Q85647635 P921 Q85647635-9251FC3B-2C35-4A1F-92CC-7A991586C3E1 @default.
• Q85647635 P356 J.JURO.2012.11.022 @default.
• Q85647635 P698 23234632 @default.
• Q85647635 P1433 Q15709979 @default.
• Q85647635 P1476 "Denosumab treatment of prostate cancer with bone metastases and increased urine N-telopeptide levels after therapy with intravenous bisphosphonates: results of a randomized phase II trial" @default.
• Q85647635 P2093 "Guozhi Gao" @default.
• Q85647635 P2093 "Karim Fizazi" @default.
• Q85647635 P2093 "Linda Bosserman" @default.
• Q85647635 P2093 "Richard Markus" @default.
• Q85647635 P2093 "Tomas Skacel" @default.
• Q85647635 P304 "S51-7; discussion S57-8" @default.
• Q85647635 P31 Q13442814 @default.
• Q85647635 P356 "10.1016/J.JURO.2012.11.022" @default.
• Q85647635 P433 "1 Suppl" @default.
• Q85647635 P478 "189" @default.
• Q85647635 P577 "2013-01-01T00:00:00Z" @default.
• Q85647635 P698 "23234632" @default.

• next